Malnutrition-Inflammation Modifies the Relationship of Cholesterol with Cardiovascular Disease

被引:37
作者
Contreras, Gabriel [1 ]
Hu, Bo [2 ]
Astor, Brad C. [3 ,4 ]
Greene, Tom [5 ]
Erlinger, Thomas [6 ]
Kusek, John W. [7 ]
Lipkowitz, Michael [8 ]
Lewis, Julia A. [9 ]
Randall, Otelio S. [10 ]
Hebert, Lee [11 ]
Wright, Jackson T., Jr. [12 ]
Kendrick, Cynthia A. [2 ]
Gassman, Jennifer [2 ]
Bakris, George [13 ]
Kopple, Joel D. [14 ,15 ,16 ,17 ]
Appel, Lawrence J. [3 ,4 ]
机构
[1] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USA
[2] Cleveland Clin Fdn, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA
[3] Johns Hopkins Univ, Sch Med, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[4] Bloomberg Sch Publ Hlth, Baltimore, MD USA
[5] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA
[6] Seton Hosp, Dept Med, Austin, TX USA
[7] Natl Inst Diabet & Kidney Dis, Bethesda, MD USA
[8] Mt Sinai Sch Med, Dept Med, New York, NY USA
[9] Vanderbilt Univ, Dept Med, Nashville, TN USA
[10] Howard Univ, Dept Med, Washington, DC 20059 USA
[11] Ohio State Univ, Dept Med, Columbus, OH 43210 USA
[12] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA
[13] Univ Chicago, Pritzker Sch Med, Dept Prevent Med, Chicago, IL 60637 USA
[14] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Harbor Univ Calif Los Angeles Med Ctr, Torrance, CA USA
[15] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Harbor Univ Calif Los Angeles Med Ctr, Los Angeles, CA 90095 USA
[16] Univ Calif Los Angeles, Sch Publ Hlth, Torrance, CA USA
[17] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2010年 / 21卷 / 12期
关键词
C-REACTIVE PROTEIN; HYPERTENSIVE KIDNEY-DISEASE; TYPE-2; DIABETES-MELLITUS; HEMODIALYSIS-PATIENTS; BLOOD-PRESSURE; AFRICAN-AMERICAN; MORTALITY; RISK; INTERLEUKIN-6; ASSOCIATION;
D O I
10.1681/ASN.2009121285
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
In moderate and severe CKD, the association of cholesterol with subsequent cardiovascular disease (CVD) is weak. We examined whether malnutrition or inflammation (M-I) modifies the risk relationship between cholesterol levels and CVD events in African Americans with hypertensive CKD and a GFR between 20 and 65 ml/min per 1.73 m(2). We stratified 990 participants by the presence or absence of M-I, defined as body mass index <23 kg/m(2) or C-reactive protein >10 mg/L at baseline. The primary composite outcome included cardiovascular death or first hospitalization for coronary artery disease, stroke, or congestive heart failure occurring during a median follow-up of 77 months. Baseline total cholesterol (212 +/- 48 versus 212 +/- 44 mg/dl) and overall incidence of the primary CVD outcome (19 versus 21%) were similar in participants with (n = 304) and without (n = 686) M-I. In adjusted analyses, the CVD composite outcome exhibited a significantly stronger relationship with total cholesterol for participants without M-I than for participants with M-I at baseline (P < 0.02). In the non M-I group, the cholesterol-adjusted hazard ratio (HR) for CVD increased progressively across cholesterol levels: HR = 1.19 [95% CI; 0.77, 1.84] and 2.18 [1.43, 3.33] in participants with cholesterol 200 to 239 and >= 240 mg/dl, respectively (reference: cholesterol <200). In the M-I group, the corresponding HRs did not vary significantly by cholesterol level. In conclusion, the presence of M-I modifies the risk relationship between cholesterol level and CVD in African Americans with hypertensive CKD.
引用
收藏
页码:2131 / 2142
页数:12
相关论文
共 47 条
[1]   Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis - A randomized controlled trial [J].
Agodoa, LY ;
Appel, L ;
Bakris, GL ;
Beck, G ;
Bourgoignie, J ;
Briggs, JP ;
Charleston, J ;
Cheek, D ;
Cleveland, W ;
Douglas, JG ;
Douglas, M ;
Dowie, D ;
Faulkner, M ;
Gabriel, A ;
Gassman, J ;
Greene, T ;
Hall, Y ;
Hebert, L ;
Hiremath, L ;
Jamerson, K ;
Johnson, CJ ;
Kopple, J ;
Kusek, J ;
Lash, J ;
Lea, J ;
Lewis, JB ;
Lipkowitz, M ;
Massry, S ;
Middleton, J ;
Miller, ER ;
Norris, K ;
O'Connor, D ;
Ojo, A ;
Phillips, RA ;
Pogue, V ;
Rahman, M ;
Randall, OS ;
Rostand, S ;
Schulman, G ;
Smith, W ;
Thornley-Brown, D ;
Tisher, CC ;
Toto, RD ;
Wright, JT ;
Xu, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (21) :2719-2728
[2]   Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans [J].
Appel, Lawrence J. ;
Wright, Jackson T., Jr. ;
Greene, Tom ;
Kusek, John W. ;
Lewis, Julia B. ;
Wang, Xuelei ;
Lipkowitz, Michael S. ;
Norris, Keith C. ;
Bakris, George L. ;
Rahman, Mahboob ;
Contreras, Gabriel ;
Rostand, Stephen G. ;
Kopple, Joel D. ;
Gabbai, Francis B. ;
Schulman, Gerald I. ;
Gassman, Jennifer J. ;
Charleston, Jeanne ;
Agodoa, Lawrence Y. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (08) :832-839
[3]   Factor analysis of risk variables associated with low-grade inflammation [J].
Aronson, Doron ;
Avizohar, Ophir ;
Levy, Yishai ;
Bartha, Peter ;
Jacob, Giris ;
Markiewicz, Walter .
ATHEROSCLEROSIS, 2008, 200 (01) :206-212
[4]   N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease - The African American Study of Kidney Disease and Hypertension (AASK) [J].
Astor, B. C. ;
Yi, S. ;
Hiremath, L. ;
Corbin, T. ;
Pogue, V. ;
Wilkening, B. ;
Peterson, G. ;
Lewis, J. ;
Lash, J. P. ;
Van Lente, F. ;
Gassman, J. ;
Wang, X. ;
Bakris, G. ;
Appel, L. J. ;
Contreras, G. .
CIRCULATION, 2008, 117 (13) :1685-1692
[5]   Study of Heart and Renal Protection (SHARP) [J].
Baigent, C ;
Landry, M .
KIDNEY INTERNATIONAL, 2003, 63 :S207-S210
[6]   Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients [J].
Bologa, RM ;
Levine, DM ;
Parker, TS ;
Cheigh, JS ;
Serur, D ;
Stenzel, KH ;
Rubin, AL .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (01) :107-114
[7]   Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines [J].
Bolton, CH ;
Downs, LG ;
Victory, JGG ;
Dwight, JF ;
Tomson, CRV ;
Mackness, MI ;
Pinkney, JH .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (06) :1189-1197
[8]   Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclerosis, and cardiomyopathy in patients undergoing long-term hemodialysis [J].
deFilippi, C ;
Wasserman, S ;
Rosanio, S ;
Tiblier, E ;
Sperger, H ;
Tocchi, M ;
Christenson, R ;
Uretsky, B ;
Smiley, M ;
Gold, J ;
Muniz, H ;
Badalamenti, J ;
Herzog, C ;
Henrich, W .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (03) :353-359
[9]   MORTALITY RISK-FACTORS IN PATIENTS TREATED BY CHRONIC-HEMODIALYSIS - REPORT OF THE DIAPHANE COLLABORATIVE STUDY [J].
DEGOULET, P ;
LEGRAIN, M ;
REACH, I ;
AIME, F ;
DEVRIES, C ;
ROJAS, P ;
JACOBS, C .
NEPHRON, 1982, 31 (02) :103-110
[10]   In vivo anti-inflammatory effect of statins is mediated by nonsterol mevalonate products [J].
Diomede, L ;
Albani, D ;
Sottocorno, M ;
Donati, MB ;
Bianchi, M ;
Fruscella, P ;
Salmona, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (08) :1327-1332